Home » Topics » BioWorld Science

BioWorld Science
RSS

Methylphenidate improves executive functioning in patients with VCI

Jan. 14, 2020

Remdesivir as a potential new therapeutic option for MERS-CoV

Jan. 14, 2020

Jacobio-Beta Pharmaceuticals, Beijing Jacobio Pharmaceuticals patent BET inhibitors

Jan. 14, 2020

PTC Therapeutics describes new compounds for treating Huntington's disease

Jan. 14, 2020

RNF208 as a prognostic biomarker in TNBC

Jan. 14, 2020

Topline data presented from TRILOGY 1 study of CaPre

Jan. 14, 2020

New preclinical data support PBI-05204 as a potential treatment for GBM

Jan. 14, 2020

BioMarin to initiate clinical testing of BMN-307 gene therapy

Jan. 14, 2020

AMO Pharma opens enrollment in pivotal trial of AMO-02 for congenital myotonic dystrophy

Jan. 14, 2020

Stem cell-based approach to spinal cord injuries developed

Jan. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...